GoodRx (GDRX) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free GDRX Stock Alerts $7.87 +0.31 (+4.10%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 10:40 AM | prnewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRxMay 30 at 4:05 PM | businesswire.comSimon Patterson Joins GoodRx Board of DirectorsMay 30 at 2:51 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against GoodRx Holdings, Inc. - GDRXMay 30 at 8:35 AM | businesswire.comGoodRx Named One of the 2024 TIME100 Most Influential CompaniesMay 30 at 6:45 AM | prnewswire.comLevi & Korsinsky Reminds GoodRx Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRXMay 30 at 6:01 AM | marketbeat.comTrexquant Investment LP Increases Stock Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)Trexquant Investment LP grew its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 396.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 155,853 shares of the company's stock after purchasing an additional 124,468May 29, 2024 | prnewswire.comShareholders that lost money on GoodRx Holdings, Inc.(GDRX) should contact The Gross Law Firm about pending Class Action - GDRXMay 29, 2024 | markets.businessinsider.comIMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the FirmMay 28, 2024 | prnewswire.comROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRXMay 28, 2024 | prnewswire.comGDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud LawsuitMay 28, 2024 | seekingalpha.comGoodRx: Encouraging Profit Stabilization (Rating Upgrade)May 27, 2024 | markets.businessinsider.comGoodRx Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GDRXMay 27, 2024 | stockhouse.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRxMay 27, 2024 | prnewswire.comGDRX Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges GDRX Investors with Losses to Contact the FirmMay 25, 2024 | americanbankingnews.comGoodRx (NASDAQ:GDRX) Shares Gap Up to $7.20May 24, 2024 | markets.businessinsider.comShareholders Who Lost Money on GoodRx Holdings, Inc.(GDRX) should contact Levi & Korsinsky about pending Class Action - GDRXMay 24, 2024 | prnewswire.comGDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud LawsuitMay 24, 2024 | americanbankingnews.comGoodRx (NASDAQ:GDRX) Rating Increased to Outperform at Royal Bank of CanadaMay 23, 2024 | msn.comRBC Capital raises GoodRx to outperform, cites growth opportunitiesMay 23, 2024 | msn.comRBC Capital Upgrades GoodRx Holdings (GDRX)May 23, 2024 | markets.businessinsider.comGoodRx Holdings Sell Rating: Navigating Strategic Shifts and Industry TrendsMay 23, 2024 | markets.businessinsider.comInvestors who lost money on GoodRx Holdings, Inc. (GDRX) should contact Levi & Korsinsky about pending Class Action - GDRXMay 23, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Upgraded at Royal Bank of CanadaRoyal Bank of Canada raised GoodRx from a "sector perform" rating to an "outperform" rating and upped their price objective for the stock from $8.00 to $10.00 in a report on Thursday.May 23, 2024 | prnewswire.comContact Levi & Korsinsky by June 21, 2024 Deadline to Join Class Action Against GoodRx Holdings, Inc. (GDRX)May 22, 2024 | businesswire.comGoodRx Offers Discounts of Up to 43% On Fertility TreatmentsMay 21, 2024 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRXMay 21, 2024 | prnewswire.comGDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud LawsuitMay 21, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Stock Price Up 2.8% After Analyst UpgradeGoodRx (NASDAQ:GDRX) Stock Price Up 2.8% Following Analyst UpgradeMay 20, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Given New $10.00 Price Target at BarclaysBarclays lifted their target price on shares of GoodRx from $9.00 to $10.00 and gave the company an "overweight" rating in a research note on Monday.May 19, 2024 | marketbeat.comJump Financial LLC Purchases 125,028 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)Jump Financial LLC grew its position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 568.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 147,011 shares of the company's stock after buying an additional 125,028 shares duriMay 17, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Shares Down 4.5% GoodRx (NASDAQ:GDRX) Stock Price Down 4.5%May 17, 2024 | msn.comRaymond James Upgrades GoodRx Holdings (GDRX)May 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against GoodRx Holdings, Inc. - GDRXMay 16, 2024 | businesswire.comKirby McInerney LLP Reminds GoodRx Holdings, Inc. (GDRX) Investors of Class Action Filing and Encourages Investors to Contact the FirmMay 16, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Shares Gap Up on Analyst UpgradeGoodRx (NASDAQ:GDRX) Shares Gap Up Following Analyst UpgradeMay 16, 2024 | marketbeat.comTD Cowen Increases GoodRx (NASDAQ:GDRX) Price Target to $16.00TD Cowen boosted their price objective on shares of GoodRx from $14.00 to $16.00 and gave the company a "buy" rating in a research report on Thursday.May 16, 2024 | markets.businessinsider.comKeyBanc Remains a Buy on GoodRx Holdings (GDRX)May 16, 2024 | msn.comGoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare moversMay 16, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Rating Increased to Outperform at Raymond JamesRaymond James raised shares of GoodRx from a "market perform" rating to an "outperform" rating and set a $10.00 price objective for the company in a research report on Thursday.May 15, 2024 | prnewswire.comGoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPMay 15, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Trading 7.4% Higher GoodRx (NASDAQ:GDRX) Stock Price Up 7.4%May 15, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the FirmMay 15, 2024 | businesswire.comGoodRx and Kroger Sign Direct Contracting AgreementMay 15, 2024 | prnewswire.comGoodRx Holdings, Inc. Class Action: Levi & Korsinsky Reminds GoodRx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRXMay 14, 2024 | prnewswire.comGDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud LawsuitMay 14, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Barinthus Biotherapeutics (BRNS) and GoodRx Holdings (GDRX)May 14, 2024 | prnewswire.comThe Gross Law Firm Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming DeadlineMay 13, 2024 | prnewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages GoodRx Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GDRXMay 13, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming DeadlineMay 12, 2024 | markets.businessinsider.comMaintaining Hold: GoodRx’s Steady Performance and Upcoming Investor Day Insights Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. GDRX Media Mentions By Week GDRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GDRX News Sentiment▼0.230.75▲Average Medical News Sentiment GDRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GDRX Articles This Week▼155▲GDRX Articles Average Week Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Dada Nexus News Today Reddit News Today Globant News Today Marathon Digital News Today Bilibili News Today Pegasystems News Today StoneCo News Today PagSeguro Digital News Today Clarivate News Today Five9 News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GDRX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
